France is delaying an EU order for 1.8 billion doses of the BioNTech/Pfizer COVID-19 vaccine deliberate for the following two years, a German newspaper mentioned on Friday, citing EU diplomats, however Paris mentioned it backed the contract and was simply asking questions.
In its report, German day by day Die Welt mentioned the explanation for Paris’ hesitation was unclear, however diplomats had speculated that it would need French firms to play a much bigger half in vaccine manufacturing.
At current conferences of European Union ministers about vaccine orders, French representatives held up decision-making by posing technical questions and requests for clarifications, Die Welt reported.
Requested concerning the report, a spokesman for France’s Trade Ministry informed Reuters: “Opposite to what has been reported, France has formally backed the (vaccine) contract throughout the formal European Fee framework.”
“We’re asking frequent sense questions with regard to the general public well being challenges we face.”
As a consequence of large world demand for booster doses in addition to vaccines for younger folks, EU governments concern that they could be too late and lose out on the order.
“That will be a catastrophe for which France could be accountable,” Die Welt quoted one diplomat as saying.
The EU has lagged nations akin to Britain and the USA in getting its residents vaccinated towards COVID-19, inflicting tensions throughout the 27-nation bloc and prompting criticism of political leaders.
Our Requirements: The Thomson Reuters Belief Rules.